Wuxi Ruinian Industrial Co., Ltd., a famous trademark in Jiangsu Province, is a large-scale health industry group with medicine/health nutrition/health drinks/beauty cosmetics as the core
Ruinian International is a large-scale health industry group with medicine, health nutrition, health drinks, and beauty cosmetics as the core, integrating production, supply, marketing and research (Hong Kong stock code: 02010.HK). HK）。
It has Wuxi Ruinian Industrial Co., Ltd., Nanjing Ruinian Best Pharmaceutical Co., Ltd., Wuxi Zhengqian Biotechnology Co., Ltd., Wuxi Yinqian Biotechnology Co., Ltd., Wuxi Ruinian Pharmaceutical Co., Ltd., Anhui Shuangke Pharmaceutical Co., Ltd., Anhui Sangtian Green Food Co., Ltd., Jiangsu Qianju Industrial Co., Ltd. and other standardized and specialized production and operation enterprises that have passed the national GMP certification.
For more than 20 years, it has always adhered to the business philosophy of "adhering to the quality of conscience and abandoning quick success", carefully developed products and served customers attentively, and has now become a leading brand in the industry of oral amino acids, ophthalmic drugs, antineoplastic drugs and other industries.
The group has a number of pharmaceutical production, R&D and sales enterprises with Nanjing Ruinian Best Pharmaceutical Co., Ltd. as the core, among the many drugs in Ruinian, ophthalmic surgery drugs and single-dose ophthalmic drugs have become the first brand in China, and the exclusive anti-tumor drug "Topotecan Hydrochloride Capsule" is a well-known brand in China;
There are a number of health and nutrition production, research and development, sales enterprises with Wuxi Ruinian Industrial Co., Ltd. as the core, Ruinian has become the first brand of oral amino acids in China, well-known and well-known, with a market share of 42.3%;
There are health drink production, R&D and sales enterprises with Wuxi Zhengqian Biotechnology Co., Ltd. as the core, and Shunpai herbal tea and amino acid functional drinks have become well-known brands in China.
Ruinian adopts the world's most advanced "blow-fill-seal" three-in-one single-dose sterile canning equipment to produce high-end surgical eye drugs to ensure that the products are sterile, safe, convenient and all-round solutions to eye diseases.
The oral anti-tumor drugs developed and produced by Ruinian have filled a number of gaps at home and abroad, opened up a new world for the research and development of tumor drugs, and brought good news to many patients. "Xinze Topotecan Hydrochloride Capsule" (Sinopharm Zhunzi H20070203, Sinopharm Zhunzi H20070204) is the earliest antineoplastic drug in oral dosage form among similar products, which effectively inhibits small cell lung cancer, ovarian cancer and cervical cancer, and is recognized as a high-tech product.
While developing and growing, Ruinian actively engages in public welfare undertakings and has the courage to assume social responsibility. In the face of every disaster, from floods to snowstorms, from typhoons to earthquakes, from SARS to "Influenza A", whenever people are affected by disasters and their health is threatened, Ruinian has reached out to help and dedicated love as quickly as possible, donated money and medicine many times, helped the injured people recover as soon as possible, and assisted the people in the disaster area to rebuild their homes.
The rapid development of Ruinian has received attention and affirmation from all walks of life. Ruinian has been rated as "High-tech Enterprise in Jiangsu Province", "Contract-honoring and Trustworthy Unit", "Famous Enterprise in Jiangsu Province", "Excellent Overseas Chinese Enterprise in Jiangsu Province", "Famous Trademark in Jiangsu Province" and so on.
In the future, Ruinian will continue to devote itself to the development of high-end drugs, high-end health nutrition products, high-end health drinks and high-end beauty cosmetics, and actively expand health management, rehabilitation medicine, medical equipment, elderly care, leisure and health care and other health fields, so as to become a leading enterprise in China's health industry and an internationally renowned enterprise.
